RanBPM is a recently identified scaffold protein that links and modulates interactions between cell surface receptors and their intracellular signaling pathways. RanBPM has been shown to interact with a variety of functionally unrelated proteins; however, its function remains unclear. Here, we show that RanBPM is essential for normal gonad development as both male and female RanBPM−/− mice are sterile. In the mutant testis there was a marked decrease in spermatogonia proliferation during postnatal development. Strikingly, the first wave of spermatogenesis was totally compromised, as seminiferous tubules of homozygous mutant animals were devoid of post-meiotic germ cells. We determined that spermatogenesis was arrested around the late pachytene-diplotene stages of prophase I; surprisingly, without any obvious defect in chromosome synapsis. Interestingly, RanBPM deletion led to a remarkably quick disappearance of all germ cell types at around one month of age, suggesting that spermatogonia stem cells are also affected by the mutation. Moreover, in chimeric mice generated with RanBPM−/− embryonic stem cells all mutant germ cells disappeared by 3 weeks of age suggesting that RanBPM is acting in a cell-autonomous way in germ cells. RanBPM homozygous mutant females displayed a premature ovarian failure due to a depletion of the germ cell pool at the end of prophase I, as in males. Taken together, our results highlight a crucial role for RanBPM in mammalian gametogenesis in both genders.
INTRODUCTION
Scaffolding proteins are important modulators of a variety of physiological functions. They can act as accessories to multiprotein complexes, facilitate interactions with the cell cytoskeleton and modulate signaling of receptors, depending on the protein-interacting domains included in their structure. RanBPM (also known as Ranbp9) is a scaffolding protein belonging to the family of the Ran-binding proteins (RanBPs). Although proteins of this family were originally identified as binding partners of the small Ras-like GTPase Ran, RanBPM does not contain the consensus Ran-binding domain (Beddow et al., 1995). RanBPM is a multimodular protein containing a consensus SPRY domain, which is a protein-protein interaction domain that was initially discovered in the SplA kinase and the ryanodine receptor (Ponting et al., 1997); a LisH (lissencephaly type-1-like homology) motif that is involved in protein dimerization (Gerlitz et al., 2005; Kim et al., 2004); a CTLH domain (C-terminal to LisH) of unknown function that is often found adjacent to the LisH domain; and a CRA motif that is involved in protein interaction (Menon et al., 2004). The LisH-CTLH domain is present in proteins involved in microtubule dynamics, cell migration, nucleokinesis and chromosome segregation and has been recently described in several proteins associated with RanBPM (Emes and Ponting, 2001; Kobayashi et al., 2007). Thus, it is not surprising that RanBPM has been found as a component of a large protein complex of more than 670 kDa (Kobayashi et al., 2007; Nishitani et al., 2001).
Since 2002, RanBPM has been shown to interact with more than 45 different proteins. For example, it interacts with the Met tyrosine kinase receptor facilitating activation of the Ras-Erk pathway (Wang et al., 2002). It binds the kelch-repeat protein muskelin affecting cell morphology (Valiyaveettil et al., 2008). In the immune system, it interacts with the β2-integrin LFA1 (lymphocyte function-associated antigen 1) (Denti et al., 2004), whereas in the nervous system it modulates axonal and neurite outgrowth by affecting the plexin-A receptors, the neural cell adhesion molecule L1 signaling and the neurotrophin receptor TrkB (Cheng et al., 2005; Murrin and Talbot, 2007; Togashi et al., 2006; Yin et al., 2010). In the embryonic neocortex, RanBPM is associated with the citron kinase (CITK), possibly affecting mitosis rate during production of pyramidal neurons (Chang et al., 2010). RanBPM has been involved in disease also. For example, it has been shown to regulate the processing of the amyloid precursor protein APP and amyloid β generation by interacting with the lipoprotein receptor-related protein Lrp, App itself and Bace1, components of pathways that are affected in Alzheimer's disease (Lakshmana et al., 2009). In addition, RanBPM possibly modulates the RNA binding properties of the fragile X mental retardation protein (Menon et al., 2004).
Despite the number of interacting molecules identified so far, the biological significance of these interactions with RanBPM is still unknown. By gene targeting in mouse we investigated the biological function of RanBPM in mammals. Mice lacking RanBPM developed to term and reached adulthood, although some died perinatally. Surviving animals showed a severe atrophy of the gonads. Interestingly, in males, testes developed normally up to one week of age. However, afterwards, seminiferous tubules started to show a spermatogenesis defect progressively leading to testicular atrophy. The first wave of spermatogenesis was marked by large apoptosis of germ cells, strongly suggesting that spermatocytes are eliminated at the late pachytene-diplotene stages of prophase I. Moreover, RanBPM might affect the maintenance of spermatogonia stem cells. Interestingly, fertility in knockout females was also compromised owing to a germ cell loss before reaching the dictyate arrest. Taken together, our data show that mammalian RanBPM plays a crucial role in both spermatogenesis and oogenesis.
MATERIALS AND METHODS
Generation of RanBPM−/− mice
RanBPM−/− mice were generated from a gene-trap RanBPM embryonic stem cell line (Baygenomics database, cell line ID: RHA056). By RT-PCR, we confirmed that the βGeo-containing gene-trap cassette was inserted in the intron following the first RanBPM coding exon. Mutant embryonic stem (ES) cells were injected into C57BL/6CR blastocysts by standard methods to generate chimeric mice that transmitted the mutated allele to their offspring (Reid and Tessarollo, 2009). RanBPM+/− mice were backcrossed to the C57BL/6CR background for at least six generations before intercrossing to verify that the observed phenotype was not affected by variations in the genetic background. Mice group-housed under standard conditions with food and water available ad libitum were maintained on a 12 hour light/dark cycle and fed a standard chow diet containing 6% crude fat. All experiments were performed in compliance with the National Institutes of Health guidelines for animal care and use of experimental animals.
RanBPM−/− ES cells were generated by growing RanBPM+/− cells in 2 mg/ml G418. Three out of the six clones that had lost the second allele of RanBPM were used to generate chimeras.
Immunoprecipitation and western blot analysis of brain and testis lysates
Brains and testes from wild-type (WT) and RanBPM−/− mice were homogenized in RIPA lysis buffer (50 mM Tris HCl pH 7.5, 150 mM NaCl, 2 mM EDTA, 1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS, protease inhibitors). Immunoprecipitation of RanBPM from brain lysates was performed overnight at 4°C using a goat anti-RanBPM antibody (AbCam) or an isotype goat serum for negative controls. Proteins were separated by SDS-PAGE, transferred to a PVDF membrane and blotted with a rabbit anti-RanBPM antibody (1:2000, AbCam). Inputs were blotted with an HRP-conjugated anti-β-actin antibody (1:5000, AbCam) to control for loading.
Histological analysis and immunohistochemistry
Mice were euthanized by CO2 asphyxiation. Testes and ovaries were collected and fixed overnight in 10% formalin and processed for standard Hematoxylin and Eosin staining (H&E). For BrdU labeling, mice received an intraperitoneal injection of 5-bromo-2′-deoxyuridine (BrdU; 150 mg per kg body weight) and were sacrificed 2 hours later. For TUNEL analysis (terminal deoxynucleotidyl transferase-mediated deoxyuridine nick end labeling), sections were stained using the ApopTag kit (Millipore) according to the manufacturer's instructions and counterstained with Eosin. Proliferating cell nuclear antigen (PCNA) labeling was performed using a DAKO ARK Kit, with the PCNA antibody (DAKO) used at 1:50 for 1 hour. Sections were counterstained with Gill's Hematoxylin. Primary antibodies were rabbit anti-MVH (AbCam, 1:500), mouse anti-γH2AX (Millipore, 1:500), rabbit anti-RanBPM (AbCam, 1:200) and rat anti-BrdU (Abd Serotec, 1:400). Secondary antibodies were goat anti-rabbit Alexa Fluor 546 (Invitrogen, 1:1000) and goat anti-mouse Alexa Fluor 488 (Invitrogen, 1:1000). For RanBPM and BrdU immunolabeling, the signal was amplified using biotinylated goat anti-rabbit (Vector, 1:200) or biotinylated goat anti-rat (Vector, 1;200) and either streptavidin Texas Red (Vector, 1:400) or the VectaStain ABC kit (Vector) following the manufacturer's recommendations. Slides were examined using an Axioplan 2 or an Axio Imager Z1 microscope (Zeiss) and pictures were taken using AxioCam HRc and AxioCam MRm cameras (Zeiss) controlled by the Axiovision software.
β-Galactosidase staining
Testes and ovaries were collected, quickly washed with PBS and cryoprotected overnight in PBS containing 30% sucrose. Tissues were then embedded in 7.5% gelatin, 10% sucrose in PBS, frozen and stored at −80°C. Cryostat sections (16 μm) were mounted on Superfrost Plus slides (Fisher Scientific) and stained by incubation for several hours to overnight at 32°C in a 4 mg/ml X-Gal (Sigma), 5 mM potassium ferrocyanide, 5 mM potassium ferricyanide, 2 mM MgCl2 and 0.25% Triton X-100 solution in PBS. Slides were then counterstained with Neutral Red.
RT-PCR
Total RNA was extracted from 3-week-old WT and RanBPM−/− mice testes using an RNeasy mini kit (Qiagen) and treated with DNase I (Roche). First-strand cDNA was generated by reverse transcription of 500 ng of RNA using the Superscript III first-strand synthesis system (Invitrogen) and random hexamer oligonucleotides. PCR [1 minute at 94°C, 1 minute at 58°C and 1 minute at 72°C (22 cycles) followed by a 5 minute elongation at 72°C] was performed using a PCR Master Mix (Promega). The primers used were described previously (Tanaka et al., 2000) except for Hsp70.2 (F: AGTCATCACTGTTCCTGCCTA; R: TAGAGCGAGTCGATCTCTATG) and β-actin (F: GATGGTGGGAATGGGTCAGAA; R: TGGCGTGAGGGAGAGCATAGC). GAPDH and β-actin were used as controls.
Spermatocyte spread preparation and immunofluorescence
Surface spreads of spermatocytes was prepared as described previously (Peters et al., 1997). Briefly, cells were spread in a hypotonic solution directly on the slide and stained for immunofluorescence with rabbit anti-SCP3 (AbCam, 1:500) and anti-γH2AX (Millipore, 1:500) antibodies. Secondary antibodies were goat anti-rabbit Alexa Fluor 546 (Invitrogen, 1:1000) and goat anti-mouse Alexa Fluor 488 (Invitrogen, 1:1000). Images were acquired with an Axioplan 2 microscope (Carl Zeiss Microimaging) and a CCD camera (Photometrics NU200) and processed using SmartCapture 2 software (Digital Scientific, UK). The number of diplotene spermatocytes was expressed as a percentage of the total number of spermatocytes.
Superovulation
Three-week-old female mice were injected intraperitoneally with 0.1 ml of Pregnant Mare Serum Gonadotropin (PMSG; 5IU; Sigma Aldrich). Mice were killed 45 hours later and ovaries were collected for histological analysis.
RESULTS
RanBPM−/− mice exhibit partial neonatal lethality and postnatal growth retardation
To investigate the in vivo biological function of RanBPM, we generated mice from embryonic stem cells targeted by gene trap in the first intron of the RanBPM gene. The gene trap vector generates a fusion transcript comprising the first ATG containing exon and the βGeo cassette encoding a fusion gene between the β-galactosidase (β-gal) and the neomycin resistance gene (Fig. 1A,B). To determine the effectiveness of the gene trap, brains, which express RanBPM at high levels, were lysed and lysates were immunoprecipitated and analyzed by western blot using an anti-RanBPM antibody. As shown in Fig. 1C, RanBPM was detected in WT but not RanBPM−/− brain lysates, confirming that the targeting effectively prevented the production of the RanBPM protein.
RanBPM homozygous mutant mice were viable, yet only ~10%, rather than the expected 25% mutant mice, were obtained from intercrosses of heterozygous mice at weaning age. At embryonic day (E)17.5, RanBPM−/− mice were present at the expected frequency, suggesting that the missing mutant mice died postnatally. Indeed, we found that most homozygous mutant mice died immediately after birth for reasons that are still unknown. RanBPM−/− mice that survived after birth had a normal life span, although they were significantly smaller than their normal littermates (Fig. 1D). The sizes of the main RanBPM−/− organs, including brain, heart, liver, lung, kidney, thymus, spleen and intestine were normal relative to the body size and showed no obvious histological defect (data not shown). By contrast, testes and ovaries were strikingly smaller compared with those of WT littermates, and mice of both genders were sterile (Fig. 1E,F).
Spermatogenesis is severely compromised in RanBPM−/− males
To investigate the cause of the sterility, we first performed an histological examination of 6-week-old RanBPM−/− mouse testes. Contrary to same stage control testes, in which seminiferous tubules were filled with germ cells produced by the spermatogenesis process, seminiferous tubules of RanBPM−/− mice were very small and almost completely devoid of germ cells (Fig. 2A,B). The few germ cells still present at this stage were undergoing apoptosis (data not shown). The epididymal duct lumen also lacked sperm (Fig. 2C,D). In older males, we observed that seminiferous tubules were completely empty and undergoing degeneration (Fig. 2E,F). Taken together, these data show that the spermatogenesis process is severely impaired in RanBPM−/− male mice, highlighting the essential role of RanBPM for normal male reproductive function. Interestingly, hormone levels in adult male mice, including follicle-stimulating hormone (FSH), luteinizing hormone (LH) and testosterone were comparable to those of control littermates, suggesting an intrinsic role for RanBPM in testis development (data not shown).
Spermatogonia proliferation is reduced in RanBPM−/− mice
To investigate at which stage testicular function starts to be affected by the mutation, we examined mutant testes at different time points of postnatal development. At postnatal day (P)0, no difference in testis size was observed between WT and RanBPM−/− mice (not shown) and H&E staining revealed normal-sized tubules (Fig. 3A,B). Moreover, using PCNA staining, a marker of proliferation that labels cells in late G1 and S-phase of the cell cycle, we observed proliferating Sertoli cells in both RanBPM−/− and control mice (Fig. 3C,D). Gonocytes were also present in RanBPM−/− seminiferous tubules, suggesting that the migration of primordial germ cells (PGC) occurred normally (Fig. 3D, arrows). No significant cell death was detected by TUNEL at this stage, either in the WT or in the mutant (data not shown). Similar results were observed at P5: testis size and histology still appeared normal in mutants and germ cell death was absent (Fig. 3E-H). These results suggest that gonocytes migrate normally to the basement membrane of the seminiferous tubules to become undifferentiated type A spermatogonia, the spermatogonial stem cells (SCC).
The second week of male mouse postnatal development is marked by an important proliferation of germ cells along with an increase in testis volume. At this time, we started to see a difference in testis size between RanBPM−/− and WT mice coupled to a significant difference in seminiferous tubules size (Fig. 3I,J; data not shown). RanBPM−/− tubules were smaller than WT and, although spermatocytes entering meiosis were visible in control testicular sections, they were less numerous on sections from the mutant. Moreover, in RanBPM−/− seminiferous tubules, germ cell layers seemed to be less organized and the number of spermatogonia, as well as spermatocytes, appeared to be decreased as revealed by PCNA staining (Fig. 3K,L).
To investigate whether there was a difference in germ cell proliferation, we checked the proliferative status of spermatogonia by in vivo incorporation of BrdU at P8. We found that, contrary to WT testis, where tubules are often delineated by a continuous ring of proliferating spermatogonia, mutant tubules had only sparse and significantly reduced BrdU labeling (Fig. 3M-O). Taken together, these data suggest that the lack of RanBPM affects the proliferation of germ cells after the first week, a time of active mitotic production of spermatogonia.
The first wave of spermatogenesis is abrogated at early meiosis I in RanBPM−/− mice
Histological analysis of pubertal (3-week-old) RanBPM−/− mouse testis showed that spermatogonia and spermatocytes were present, but post-meiotic cells, i.e. spermatids, were absent, suggesting that the first wave of germ line differentiation did not take place (Fig. 4A-B′). To investigate whether this defect was caused by apoptosis of the germinal cell lineage, we carried out a TUNEL assay. As shown in Fig. 4C-D′, a large number of cells were labeled in the mutant testis, whereas only a few apoptotic cells were detected in the WT testis. These results indicate that, instead of progressing through meiosis, mutant spermatocytes undergo apoptosis and are subsequently eliminated from the seminiferous tubules. To determine more precisely at which meiotic stage the cell differentiation process is disrupted, we performed an RT-PCR expression analysis for stage-specific markers of spermatogenic germ cells at 3 weeks of age, when apoptosis in the mutant was first detected. Genes that display the earliest expression such as A-myb (Mybl1 – Mouse Genome Informatics), which is expressed in spermatogonia and spermatocytes to the pachytene stage (Mettus et al., 1994), Dmc1, expressed in leptotene to zygotene spermatocytes (Yoshida et al., 1998) and Hsp70.2 (Hspa2 – Mouse Genome Informatics), expression of which is abundant in primary spermatocytes and subsequently decreases in the post-meiotic stages (Rosario et al., 1992; Zakeri et al., 1988), were expressed normally in RanBPM−/− mice (Fig. 4E). The Scp1 (Sycp1 – Mouse Genome Informatics) and Scp3 (Sycp3 – Mouse Genome Informatics) genes, encoding synaptonemal complex proteins (Klink et al., 1997; Meuwissen et al., 1992), were also expressed at normal levels, demonstrating the presence of pachytene spermatocytes in mutant mice. However, the expression of calmegin (Watanabe et al., 1994) and Hox1.4 (Hoxa4 – Mouse Genome Informatics) (Rubin et al., 1986), which starts at the pachytene and persists through the spermatid stage, was significantly reduced in RanBPM−/− mice. Moreover, cyclin A1, the level of which has been reported to be upregulated in late pachytene spermatocytes and to peak in diplotene cells, was dramatically reduced (Sweeney et al., 1996). Taken together, these data suggest that in RanBPM−/− mice, spermatogenesis is arrested around the late pachytene/diplotene stages of meiotic prophase I.
These observations prompted us to investigate in more details the progression of spermatocytes through meiotic prophase I. Prophase of the first meiotic division involves the pairing, synapsis, recombination and disjunction of homologous chromosomes following tightly regulated mechanisms. Analysis of the synaptonemal complex (SC), a tripartite protein structure that connects paired chromosomes along their entire length (Page and Hawley, 2004), by immunodetection of synaptonemal complex protein 3 (Scp3), a structural component of the axial and lateral elements of the SC (Yuan et al., 2000) showed no difference between the staining pattern of WT and RanBPM−/− pachytene and diplotene spermatocytes (Fig. 4F). However, although the formation of the SC appeared to occur normally in mutant cells, the number of diplotene spermatocytes was 60-90% lower than controls (n=3 for each genotype), in accordance with the RT-PCR results. The distribution of phosphorylated histone γH2AX (H2afx – Mouse Genome Informatics), that marks sites of double stranded breaks at the leptotene stage and subsequently converges around the sex chromosomes to form the sex body (Mahadevaiah et al., 2001), also appeared normal in mutant spermatocytes (Fig. 4F), suggesting that synapsis occurs normally in RanBPM−/− mice during the first wave of spermatogenesis.
RanBPM is widely and dynamically expressed in the testis
Our data suggest a crucial role for RanBPM in the initiation and maintenance of spermatogenesis. To understand better the function of RanBPM in the testis, we investigated its temporal and spatial pattern of expression by using the lacZ reporter gene. At E13.5 days of development, we did not find any RanBPM expression (data not shown). However, at E17.5, after completion of the gonocyte migration to the gonad, RanBPM was expressed in germ cells, as shown by colocalization with the MVH protein (mouse VASA homolog; Fig. 5A,B). At birth, RanBPM expression was mainly restricted to the gonocytes (Fig. 5C) whereas five days later it started to be expressed also by the interstitial cells (Fig. 5D). At 2 weeks, expression was detected in both spermatogonia and Sertoli cells (Fig. 5E). In adult mice, we observed a distinct pattern of expression depending on the stage of the seminiferous tubules, suggesting that RanBPM expression is dynamically regulated during the spermatogenic wave (Fig. 5F,G). In some tubules, it was detected in spermatogonia residing at the periphery of the tubules (Fig. 5F′). Expression was increased and maintained in both primary and secondary spermatocytes and stopped at the stage of differentiated tailed spermatids that appeared to be devoid of β-gal staining. In other tubule stages, RanBPM expression was highly increased in primary spermatocytes (Fig. 5F″). These results are in accordance with other studies that described the expression of RanBPM in cells ranging from spermatocytes to spermatids (Rossi et al., 2004). Interestingly, RanBPM expression was increased in spermatocytes undergoing meiosis. Outside the germ cell lineage, RanBPM RNA was highly expressed in Sertoli cells, the supporting cells of the spermatogenic process, and in the interstitial endocrine Leydig cells lying between the seminiferous tubules (Fig. 5F′). Taken together, these data show that RanBPM is widely expressed in the adult testis, and its expression seems to be cyclically regulated together with the waves of spermatogenesis.
Expression of RanBPM protein during postnatal development was confirmed by western blot (Fig. 5H). RanBPM protein is expressed at low levels between P1 and 2 weeks but is significantly increased during the third week and later in mature animals, in accordance with the β-gal staining data. Interestingly, immunohistochemistry analysis showed that RanBPM is particularly highly expressed in primary spermatocytes, in accordance with the lacZ expression (Fig. 5I,J). Taken together, these data show that RanBPM upregulation coincides with the beginning of spermatogenesis and is maintained during adulthood. Importantly, this is the time at which we observed the establishment of the phenotype in the testis of the mutant animals.
RanBPM functions in a cell-autonomous way in the male germ cells
Because RanBPM is expressed in both germ cells and supporting cells, we investigated next whether the spermatogenesis defect observed in the mutant mice was caused by a defect in the Sertoli cell nursing function or by a cell-autonomous defect in germ cells. To this end, we inactivated the second RanBPM allele in the targeted ES cells used to generate the mutant mouse and injected the RanBPM−/− ES cells into recipient WT blastocysts. Blastocyst injection of heterozygous (HET) ES cells used as a control showed that these cells could give rise to both Sertoli and germ cells (Fig. 6). Seminiferous tubules from 3-week-old chimeras generated with HET ES cells were similar to those from RanBPM+/− animals and contained β-gal-positive germ cells, including spermatogonia and spermatocytes (Fig. 6C and 6A, respectively). By contrast, in chimeras generated with RanBPM−/− ES cells, seminiferous tubules contained only β-gal-negative WT germ cells, whereas Sertoli cells and most interstitial cells were β-gal-positive (Fig. 6E). Importantly, in 10-day-old chimeras, we did find tubules almost uniformly stained for β-gal, suggesting that mutant cells have the ability to produce gonocytes (Fig. 6G,H). However, these cells disappeared by 3 weeks. In chimeras generated using −/− ES cells, spermatogenesis occurred normally, as spermatids could be produced from WT cells originating from the recipient blastocyts (Fig. 6F). As the supporting cells in these chimeras were derived from −/− ES cells, we suggest that RanBPM expression in Sertoli and interstitial cells is not required to support spermatogenesis (compare Fig. 6B,D and F). By contrast, the complete absence of germ cells coming from mutant ES cells in pubertal animals suggests that RanBPM acts in a cell-autonomous way in gonocytes and is crucial for the germ cell lineage.
RanBPM−/− females display a premature ovarian failure
Mating for a two-month period of 7- to 8-week-old RanBPM−/− females (n=6) to WT males failed to produce any offspring despite the presence of plugs. This observation suggested that mutant females are sterile similarly to RanBPM−/− males. Indeed, they displayed ovaries greatly reduced in size and containing only few follicles (Fig. 7). A significant decrease in the number of primary follicles was already apparent at 3 weeks of age (Fig. 7A,B) and very few follicles were detected at 2 months (Fig. 7C,D). By 7 months, mutant ovaries were cystic and devoid of follicles (Fig. 7E,F). As premature ovarian failure can result from a number of defects affecting, for example, PGC migration, the meiotic process, and the formation, survival, activation and development of primordial follicles (for a review, see Jagarlamudi et al., 2010), we first analyzed mutant ovaries starting at E17.5. At this stage, γH2AX staining did not show any abnormality in the number of meiotic oocytes, suggesting that PGC migration occurred normally (Fig. 8A,B). However, at birth, when oocytes are reaching the end of prophase I, double labeling for MVH and γH2AX showed an already sharp decrease in the number of oocytes in RanBPM−/− ovaries (Fig. 8C,D). Moreover, the percentage of TUNEL-labeled oocytes in P0 mutant ovaries was significantly higher (~20% of the total oocytes) than that detected in WT (~5% of the total oocytes; data not shown), suggesting that oocytes are lost by apoptosis between E17.5 and P0. Analysis of oocytes at P2 and P5 using the MVH marker confirmed that most oocytes were already lost before those stages (Fig. 8E,F; data not shown). The loss of oocytes at birth suggests an arrest of oocyte differentiation at the end of prophase I. RanBPM expression, analyzed by β-Gal staining in heterozygous females, showed that at E17.5 this gene is not present in ovaries (data not shown). Its expression was detected at birth when the oocytes are reaching the dictyate arrest at the end of prophase I (Fig. 8G,H). Most importantly, the onset of RanBPM expression in oocytes coincides with the time at which oocytes are lost in the mutant animals, suggesting a crucial and germ cell-autonomous role for RanBPM in the ovary. In addition, pubertal females displayed cyclic changes in vaginal impedance indicative of normal estrus cycles (data not shown), which suggests that follicle and stromal cell functions are not affected and that RanBPM plays an oocyte-intrinsic role.
Although RanBPM expression was observed in some somatic cells, such as the endocrine theca cells of ovarian follicles developing in the adult ovary, the highest expression of RanBPM was detected in the oocyte (Fig. 9). Moreover, its expression was maintained in the oocyte during follicle maturation, from primary to Graafian follicles (Fig. 9B,C).
Follicles are able to mature in RanBPM−/− ovaries
Because RanBPM is expressed in the oocyte during adulthood and mutant ovaries still contain few oocytes, we investigated whether, in addition to being crucial for normal oocyte development, RanBPM could also have a role in the maturation of ovarian follicles (Eppig et al., 2002). Analysis of ovaries from superovulated 3-week-old mice showed that mutant ovaries can form follicles to the antral stage (Fig. 9D,E). The few oocytes still present appeared normal and, relative to the ovary size, the level of apoptosis was comparable to control animals (Fig. 9F,G). Taken together, these data suggest that RanBPM does not play an essential role in the control of follicle maturation in the adult ovary, but rather affects oocyte development per se.
DISCUSSION
RanBPM is a scaffolding protein that has been involved in a variety of biological processes, particularly in the immune and nervous system (Murrin and Talbot, 2007). However, as RanBPM interacts with a broad spectrum of proteins, including membrane receptors and cytoplasmic and nuclear proteins that are functionally unrelated, its physiological role is still unknown. Here, we show that RanBPM is not essential for mouse embryonic development. However, both mouse genders are sterile because of a potentially related germ cell defect.
RanBPM expression in reproductive organs starts only in late embryonic development, both in males and females, and, at that time, is restricted to germ cells. In agreement with this expression profile, RanBPM deletion does not affect PGC migration, as gonocytes were present in seminiferous tubules at birth and E17.5 ovaries contained normal numbers of oocytes. Interestingly, in both males and females, defects were noted at the time at which germ cells enter meiosis.
The prophase of the first meiotic division involves genetic recombination, pairing of homologous chromosomes and formation of the synaptonemal complex (SC). SCs are zipper-like structures that are assembled between the chromosomes pairs at the pachytene stage (Cohen and Pollard, 2001; Zickler and Kleckner, 1999). The disruption of various genes leads to meiotic arrest and subsequent apoptotic cell death in the testis (Cooke and Saunders, 2002; de Rooij and de Boer, 2003; Matzuk and Lamb, 2002). For example, in mice with null mutations in the DNA repair gene Msh4 (Kneitz et al., 2000), the cyclin-dependent kinase 2 Cdk2 (Berthet et al., 2003; Ortega et al., 2003; Viera et al., 2009), the RecA-like gene Dmc1 (Yoshida et al., 1998), the ataxia-telangiectasia mutated gene Atm (Xu et al., 1996) or the synaptonemal complex protein Scp3 (Yuan et al., 2000), chromosomes fail to undergo normal pairing causing cell death during prophase I. Moreover, recent studies indicated the existence of a pachytene checkpoint that prevents nuclear division when there is a failure in recombination or synapsis (Roeder and Bailis, 2000). In 3-week-old RanBPM−/− males, the expression levels of pachytene stage-specific genes such as Scp1 and Scp3 (Klink et al., 1997; Meuwissen et al., 1992) were normal. In addition, analysis of the structure of SCs showed that chromosome synapsis occurred normally in mutant pachytene spermatocytes. However, taking into account the upregulation of RanBPM in spermatocytes, the predominant expression of the protein in this cell type, and the apoptotic elimination of these cells during the first wave of spermatogenesis, we cannot exclude a role for RanBPM in the meiotic process.
Adult mutant females exhibited ovaries showing dysgenesis from an absence of oocytes. Premature ovarian failure has numerous causes (for reviews, see Jagarlamudi et al., 2010; Skillern and Rajkovic, 2008). The premature ovarian failure observed in RanBPM−/− mice was directly linked to an early depletion of the oocyte pool. Interestingly, RanBPM expression in the ovary starts only at birth in oocytes that are probably at the late pachytene or diplotene stage. Mutant oocytes thus seem to reach the pachytene stage normally, but, as in males, germ cell differentiation is arrested at the end of prophase I, right before oocytes reach the dictyate stage. An arrest at prophase I has been reported in female mice null for genes involved in chromosome synapsis, as in Msh4- or Cdk2-null mice (Kneitz et al., 2000; Ortega et al., 2003). However, deletion of RanBPM did not cause a phenotype as strong as the one observed in Msh4- or Cdk2-null mice, as some follicles are still present in postnatal RanBPM−/− ovaries. In mutants for the transcription factor FIGα (Figla – Mouse Genome Informatics), in which the process of primordial follicle formation is affected, oocyte numbers are normal at birth and germ cells are lost between P0 and P1 (Soyal et al., 2000). By comparison, the phenotype of RanBPM−/− females is more close to the phenotype of mutants for genes involved in the prophase of the first meiotic division, for example Dmc1, in which oocytes are lost between E17.5 and P0 (Yoshida et al., 1998). Moreover, this period corresponds to the late pachytene-diplotene, which is the time at which defects are observed in males. An arrest at the same stage of meiosis in both genders suggests the presence of a common mechanism between males and females occurring at the end of prophase I. Interestingly, mutations in several genes that are involved in the mechanisms of chromosome synapsis and recombination display sex-specific effects (Hunt and Hassold, 2002). The presence of remaining oocytes could also be explained by the fact that, even if RanBPM had a role in chromosome synapsis, this could be through its scaffolding functions, by interacting with some proteins that are directly involved in this crucial process. The ability to induce maturation of the few residual oocytes in females by superovulation supports the notion that RanBPM is required at an early stage of germ cell differentiation and not at later stages such as the orchestration of follicle maturation.
In RanBPM−/− testes, spermatocytes at the late pachytene-diplotene stage were eliminated by apoptosis and, shortly after that, all germ cells disappeared leading to Sertoli-cell-only seminiferous tubules followed by tubular degeneration. Therefore, in the developing RanBPM−/− testes, only a single and abnormal postnatal wave of spermatogenesis takes place, followed by a failure of germ cells to differentiate further. Indeed, transit-amplifying spermatogonia, labeled by BrdU incorporation, were already missing at 1 month of age (data not shown) suggesting a lack of spermatogonial stem cell (SSC) renewal. Thus, in addition to the meiotic arrest occurring during the first round of spermatogenesis, spermatogonia, which are essential to continuously provide differentiating cells and maintain the spermatogenesis process, might also be affected in their survival, differentiation or self-renewal processes by the lack of RanBPM (Oatley and Brinster, 2008).
A few genes that are important for the spermatogenesis process have been reported to interact with RanBPM, suggesting a possible functional interaction. For example, the mouse vasa homolog gene (Mvh; Ddx4 – Mouse Genome Informatics), encoding an ATP-dependent RNA helicase, is crucial for the development of male germ cells (Shibata et al., 2004; Tanaka et al., 2000). However, in Mvh-null males, germ cell differentiation stops earlier than in RanBPM−/− mice, at the zygotene stage of prophase I, and Mvh−/− females are fertile. The androgen receptor (AR) has also been reported to interact with RanBPM (Rao et al., 2002). Yet, AR knockout in the testis generates a phenotype clearly worse than the one observed in RanBPM−/− males as it leads to an abdominal localization of the testes and the absence of epididymis (Wang et al., 2009). Moreover, in contrast with RanBPM−/− females, AR-mutant females are subfertile, showing a gradual decrease in the number of follicles starting only at 3 weeks of postnatal life and probably caused by a defect in the maintenance of folliculogenesis (Shiina et al., 2006). The fact that none of these mutants has a phenotype similar to the one caused by the RanBPM deletion reinforces the hypothesis that this gene might function as a scaffolding protein involved in multiple pathways.
Up to one week after birth, RanBPM−/− testes developed normally. However, starting at postnatal day 8 we observed a significant decrease in spermatogonia proliferation without a change in the level of apoptosis, suggesting a lack of proliferation as the main cause of the testis growth defect. To date, only a few molecules have been shown to affect germ cell proliferation in the testis, the main one being the tyrosine kinase receptor Kit, which is also implicated in germ cell survival (Blume-Jensen et al., 2000; Kissel et al., 2000). RanBPM has been shown to interact with other tyrosine kinase receptors such as Met, TrkA (Ntrk1 – Mouse Genome Informatics) and TrkB (Ntrk2 – Mouse Genome Informatics) (Wang et al., 2002; Yin et al., 2010; Yuan et al., 2006). So, it would be of interest to investigate whether RanBPM does interact with Kit also and, if so, how it would affect its signaling property. Interestingly, chimera experiments performed using RanBPM-null ES cells are in agreement with this hypothesis, as they suggest a cell-autonomous role for RanBPM in germ cells, the same cell population that express Kit. Importantly, as RanBPM has been described as a scaffolding protein, a phenotype involving Kit would not be incompatible with other roles of RanBPM, such as in meiosis.
Intriguingly, a null RanBPM Drosophila mutant in genetic mosaics indicates that RanBPM regulates the cell shape, size and organization of the germinal stem cell (GSC) niche, implicating RanBPM in the control of niche capacity for GSCs (Dansereau and Lasko, 2008). Although Drosophila and mammals are evolutionarily distant, it is interesting to observe that the RanBPM gene has a conserved role in reproduction in both species. In the future, it will be of interest to identify the signaling pathways affected in RanBPM−/− mice and to investigate whether, in addition to its role in reproductive organs, the functional similarities between species extend even to the molecular level.
In summary, RanBPM affects gametogenesis in both genders, suggesting that this scaffolding protein modulates the function of multiple genes involved in the meiosis process and/or affects growth factor signaling pathways controlling germ cell proliferation, survival and renewal.
Acknowledgements
We would like to thank Drs Shyam Sharan and Esta Sterneck for helpful discussions; Susan Reid, Eileen Southon and Donna Butcher for excellent technical assistance; and Dr A. F. Parlow for performing the hormone measurements. This research was supported by the Intramural Research Program of the NCI, Center for Cancer Research, NIH. Deposited in PMC for release after 12 months.
References
Competing interests statement
The authors declare no competing financial interests.